Compound Detail
CHEMBL4437875
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4437875 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | OKZFHEZEJOOLCQ-DJZNWEJSSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
425.5
MW (Da)
4.09
ALogP
5
HBA
3
HBD
90.8
PSA (Ų)
0.41
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.09
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 8050.0 | nM | 5.09 | Cytotoxicity against human HepG2 cells assessed as cell growth inhibition after ... | 31999451 |
| SK-OV-3 | IC50 | = | 8810.0 | nM | 5.05 | Cytotoxicity against human SKOV3 cells assessed as cell growth inhibition after ... | 31999451 |
| A549 | IC50 | = | 9080.0 | nM | 5.04 | Cytotoxicity against human A549 cells assessed as cell growth inhibition after 4... | 31999451 |
| HCT-116 | IC50 | = | 9720.0 | nM | 5.01 | Cytotoxicity against human HCT116 cells assessed as cell growth inhibition after... | 31999451 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31999451 | 10.1021/acs.jmedchem.9b01386 | Indoleamine 2,3-dioxygenase 1 | 1 |
| 31999451 | 10.1021/acs.jmedchem.9b01386 | HCT-116 | 1 |
| 31999451 | 10.1021/acs.jmedchem.9b01386 | SK-OV-3 | 1 |
| 31999451 | 10.1021/acs.jmedchem.9b01386 | A549 | 1 |
| 31999451 | 10.1021/acs.jmedchem.9b01386 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine